Modeling Plasmodium vivax: Relapses, treatment, seasonality, and G6PD deficiency

Journal of Theoretical Biology

Volumn 316, Issue , 2013, Pages 25-34

  Chamchod, Farida ^a,b   Beier, John C ^c  

^a Department of Biology   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

G6PD deficiency; Plasmodium vivax; Relapse

Indexed keywords

PRIMAQUINE;

AGE; APICOMPLEXAN LIFE CYCLE STAGE; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HYPNOZOITE; INCIDENCE; INCUBATION TIME; MALARIA CONTROL; MATHEMATICAL MODEL; MOSQUITO; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; RELAPSE; SEASONAL VARIATION; SPECIES COMPARISON; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; DISEASE CARRIER; DISEASE TRANSMISSION; GROWTH, DEVELOPMENT AND AGING; HUMAN; PARASITOLOGY; PHYSIOLOGY; POPULATION DENSITY; RECURRENT DISEASE; SEASON; THEORETICAL MODEL;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

ANIMALS; COMPUTER SIMULATION; CULICIDAE; DISEASE VECTORS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALARIA, VIVAX; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PLASMODIUM VIVAX; POPULATION DENSITY; RECURRENCE; SEASONS;

EID: 84867421111     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.08.024     Document Type: Article

References (50)

1. Aguas, R., Ferreira, M.U., Gomes, M.G.M., Modeling the effects of relapse in the transmission dynamics of malaria parasites. J. Parasitol. Res., 2012, 2012, 921715.
2. Altizer, S., Dobson, A., Hosseini, P., Hudson, P., Pascual, M., Rohani, P., Seasonality and the dynamics of infectious diseases. Ecol. Lett. 9 (2006), 467–487.
3. Anderson, R.M., May, R.M., Infectious Diseases of Humans: Dynamics and Control. 1991, Oxford University Press.
4. Baird, J.K., Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 22 (2009), 508–534.
5. Baird, J.K., Hoffman, S.L., Primaquine therapy for malaria. Clin. Infect. Dis. 39 (2004), 1336–1345.
6. Brauer, F., van den Driessche, P., Wu, J., 2008. Mathematical epidemiology. In: Lecture Notes in Mathematics. Springer-Verlag, Berlin.
7. Cappellini, M.D., Fiorelli, G., Glucose-6-phosphate dehydrogenase deficiency. Lancet 371 (2008), 64–74.
8. Chamchod, F., Britton, N.F., Analysis of a vector-bias model on malaria transmission. Bull. Math. Biol. 73 (2011), 639–657.
9. Chattopadhyay, R., Velmurugan, S., Chakiath, C., Donkor, L.A., Milhous, W., Barnwell, J.W., Collins, W.E., Hoffman, S.L., Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS One, 5, 2010, e14275.
10. Chen, N., Auliff, A., Rieckmann, K., Gatton, M., Cheng, Q., Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195 (2007), 934–941.
11. Childs, D.Z., Boots, M., The interaction of seasonal forcing and immunity and the resonance dynamics of malaria. J. R. Soc. Interface 7 (2010), 309–319.
12. Cogswell, F.B., The hypnozoite and relapse in primate malaria. Clin. Microbiol. Rev. 5 (1992), 26–35.
13. Cole-Tobian, J.L., Michon, P., Biasor, M., Richards, J.S., Beeson, J.G., Mueller, I., King, C.L., Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children. Infect. Immun. 77 (2009), 4009–4017.
14. Craig, A.A., Kain, K.C., Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. J. Infect. Dis. 174 (1996), 373–379.
15. Culleton, R.L., Mita, T., Ndounga, M., Unger, H., Cravo, P.V., Paganotti, G.M., Takahashi, N., Kaneko, A., Eto, H., Tinto, H., Karema, C., D'Alessandro, U., do Rosário, V., Kobayakawa, T., Ntoumi, F., Carter, R., Tanabe, K., Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing. Malar. J., 7, 2008, e174.
16. Culleton, R., Ndounga, M., Zeyrek, F.Y., Coban, C., Casimiro, P.N., Takeo, S., Tsuboi, T., Yadava, A., Carter, R., Tanabe, K., Evidence for the transmission of Plasmodium vivax in the Republic of the Congo west Central Africa. J. Infect. Dis. 200 (2009), 1465–1469.
17. De Zoysa, A.P.K., Mendis, C., Gamage-Mendis, A.C., Weerasinghe, S., Herath, P.R.J., Mendis, K.N., A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area. Bull. World Heath Organ. 69 (1991), 725–734.
18. Diekmann, O., Heesterbeek, J.A.P., Mathematical Epidemiology of Infectious Diseases, Model Building, Analysis and Interpretation. 2000, Wiley.
19. Diekmann, O., Heesterbeek, J.A.P., Roberts, M.G., The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface 7 (2010), 873–885.
20. Dietz, K., Molineaux, L., Thomas, A., A malaria model tested in the Africa Savannah. Bull. World Health Organ. 50 (1974), 347–357.
21. Doolan, D.L., Dobano, C., Baird, J.K., Acquired immunity to malaria. Clin. Microbiol. Rev. 22 (2009), 13–36.
22. Filipe, J.A.N., Riley, E.M., Drakeley, C.J., Sutherland, C.J., Ghani, A.C., Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput. Biol., 3, 2007, e225.
23. Gage, K.L., Burkot, T.R., Eisen, R.J., Hayes, E.B., Climate and vectorborne diseases. Am. J. Prev. Med. 35 (2008), 436–450.
24. Greenwood, B., Marsh, K., Snow, R., Why do some African children develop severe malaria?. Parasitol. Today 7 (1991), 277–281.
25. Guerra, C.A., Howes, R.E., Patil, A.P., Gething, P.W., Boeckel, T.P.V., Temperley, W.H., Kabaria, C.W., Tatem, A.J., Manh, B.H., Elyazar, I.R.F., Baird, J.K., Snow, R.W., Hay, S.I., The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Neglected Trop. Dis., 4, 2009, e774.
26. Gupta, S., Day, K.P., A strain theory of malaria transmission. Parasitol. Today 10 (1994), 476–481.
27. Imwong, M., Snounou, G., Pukrittayakamee, S., Tanomsing, N., Kim, J.R., Nandy, A., Guthmann, J.P., Nosten, F., Carlton, J., Looareesuwan, S., Nair, S., Sudimack, D., Day, N.P.J., Anderson, T.J.C., White, N.J., Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195 (2007), 927–933.
28. Ishikawa, H., Ishii, A., Nagai, N., A mathematical model for the transmission of Plasmodium vivax malaria. Parasitol. Int. 52 (2003), 81–93.
29. Joshi, H., Prajapati, S.K., Verma, A., Kang'a, S., Carlton, J.M., Plasmodium vivax in India. Trends Parasitol. 24 (2008), 228–235.
30. Kammanee, A., Kanyamee, N., Tang, I.M., Basic reproduction number for the transmission of Plasmodium vivax malaria. J. Parasitol. Res., 32, 2001.
31. Keeling, M.J., Rohani, P., Modeling Infectious Diseases in Humans and Animals. 2007, Princeton University Press.
32. Kitchener, S., Nasveld, P., Edstein, M.D., Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 76 (2007), 494–496.
33. Krotoski, W.A., Discovery of the hypnozoite and a new theory of malarial relapse. Trans. R. Soc. Trop. Med. Hyg. 79 (1985), 1–11.
34. Kuwahata, M., Wijesinghe, R., Ho, M., Pelecanos, A., Bobogare, A., Landry, L., Bugora, H., Vallely, A., McCarthy, J., Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar. J., 9, 2010, 223.
35. Leslie, T., Briceño, M., Mayan, I., Mohammed, N., Klinkenberg, E., Sibley, C.H., Whitty, C.J.M., Rowland, M., The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case–control study amongst Afghan refugees in Pakistan. PLoS Med., 7, 2010, e1000283.
36. Louicharoen, C., Patin, E., Paul, R., Nuchprayoon, I., Witoonpanich, B., Peerapittayamongkol, C., Casademont, I., Sura, T., Laird, N.M., Singhasivanon, P., Quintana-Murci, L., Sakuntabhai, A., Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast asians. Science 326 (2009), 1546–1549.
37. Macdonald, G., The Epidemiology and Control of Malaria. 1957, Oxford University Press, London.
38. Maitland, K., Williams, T.N., Bennett, S., Newbold, C.I., Peto, T.E.A., Viji, J., Timothy, R., Clegg, J.B., Weatherall, D.J., The interaction between Plasmodium falciparum and Plasmodium vivax children on Espirtu Santo Island, Vanuatu. Trans. R. Soc. Trop. Med. Hyg. 90 (1996), 614–620.
39. Mendes, C., Dias, F., Figueiredo, J., Mora, V.G., Cano, J., de Sousa, B., do Rosario, V.E., Benito, A., Berzosa, P., Arez, A.P., Duffy negative antigen is no longer a barrier to Plasmodium vivax-molecular evidences from the African West Coast Angola and Equatorial Guinea. PLoS Neglected Trop. Dis., 5, 2011, e1192.
40. Mendis, K., Sina, B.J., Marchesini, P., Carter, R., The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64 (2001), 97–106.
41. Miller, L.H., Mason, S.J., Clyde, D.F., McGinniss, M.H., The resistance factor to Plasmodium vivax in blacks: the duffy-blood-group genotype, fyfy. N. Engl. J. Med. 295 (1976), 302–304.
42. Mueller, I., Galinski, M.R., Baird, J.K., Carlton, J.M., Kochar, D.K., Alonso, P.L., del Portillo, H.A., Key gaps in the knowledge of Plasmodium vivax a neglected human malaria parasite. Lancet Infect. Dis. 9 (2009), 555–566.
43. Nah, K., Kim, Y., Lee, J.M., The dilution effect of the domestic animal population on the transmission of P. vivax malaria. J. Theor. Biol. 266 (2010), 299–306.
44. Naing, C., Aung, K., Win, D., Wah, M.J., Efficacy and safety of chloroquine for patients with uncomplicated Plasmodium vivax infections in endemic countries. Trans. R. Soc. Trop. Med. Hyg., 2010, 695–705.
45. Nishiura, H., Lee, H., Cho, S., Lee, W., In, T., Moon, S., Chung, G.T., Kim, T., Estimates of short- and long-term incubation periods of Plasmodium vivax malaria in the Republic of Korea. Trans. R. Soc. Trop. Med. Hyg. 101 (2007), 338–343.
46. Price, R.N., Tjitra, E., Guerra, C.A., Yeung, S., White, N.J., Anstey, N.M., Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77 (2007), 79–87.
47. Shute, P.G., Lupascu, G., Brazei, P., Maryon, M., Constantinescu, P., Bruce-Chwatt, L.J., Draper, C.C., Killick-Kendick, R., Garnham, P.C.C., A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the length of the prepatent period. Trans. R. Soc. Trop. Med. Hyg. 70 (1977), 474–481.
48. Smith, D.L., Dushoff, J., Snow, R.W., Hay, S.I., The entomological inoculation rate and Plasmodium falciparumin African children. Nature 438 (2005), 492–495.
49. White, L.J., Maude, R.J., Pongtavornpinyo, W., Saralamba, S., Aguas, R., Effelterre, T.V., Day, N.P., White, N.J., The role of simple mathematical models in malaria elimination strategy design. Malar. J., 8, 2009, 212.
50. White, N.J., The role of anti-malarial drugs in eliminating malaria. Malar. J., 7, 2008, S8.